OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Acute severe ulcerative colitis management: unanswered questions and latest insights
Pauline Rivière, C Li Wai Suen, María Chaparro, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 251-262
Open Access | Times Cited: 23
Pauline Rivière, C Li Wai Suen, María Chaparro, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 251-262
Open Access | Times Cited: 23
Showing 23 citing articles:
Formulation, Optimization, and Evaluation of Lornoxicam-Loaded Novasomes for Targeted Ulcerative Colitis Therapy: In Vitro and In Vivo Investigations
Asmaa Badawy Darwish, Abeer Salama, Inas Essam Ibrahim Al-Samadi
Journal of drug targeting (2025), pp. 1-21
Closed Access | Times Cited: 3
Asmaa Badawy Darwish, Abeer Salama, Inas Essam Ibrahim Al-Samadi
Journal of drug targeting (2025), pp. 1-21
Closed Access | Times Cited: 3
Prior Anti-TNF Exposure Is Associated with an Increased Risk of Short- and Long-Term Colectomy in Acute Severe Ulcerative Colitis
Arno R. Bourgonje, Hannah Posner, Franck Carbonnel, et al.
Digestive Diseases and Sciences (2025)
Closed Access | Times Cited: 2
Arno R. Bourgonje, Hannah Posner, Franck Carbonnel, et al.
Digestive Diseases and Sciences (2025)
Closed Access | Times Cited: 2
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
María José Temido, Sailish Honap, Vipul Jairath, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
María José Temido, Sailish Honap, Vipul Jairath, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
Matthew C. Choy, C Li Wai Suen, Danny Con, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 11, pp. 981-996
Closed Access | Times Cited: 16
Matthew C. Choy, C Li Wai Suen, Danny Con, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 11, pp. 981-996
Closed Access | Times Cited: 16
Upadacitinib for Acute Severe Ulcerative Colitis: A Systematic Review
John Damianos, Olufemi Osikoya, Gregory Brennan
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 6
John Damianos, Olufemi Osikoya, Gregory Brennan
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 6
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial
Aurélien Amiot, Philippe Marteau, Antoine Meyer, et al.
Gut (2024), pp. gutjnl-333281
Closed Access | Times Cited: 4
Aurélien Amiot, Philippe Marteau, Antoine Meyer, et al.
Gut (2024), pp. gutjnl-333281
Closed Access | Times Cited: 4
Janus kinase inhibitors in the management of acute severe ulcerative colitis: a comprehensive review
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2025) Vol. 19, Iss. 2
Closed Access
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2025) Vol. 19, Iss. 2
Closed Access
Identification of Senescence-Related Genes for the Prediction of Ulcerative Colitis Based on Interpretable Machine Learning Models
Jingjing Ma, Chen Chen, Nian Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3431-3447
Open Access
Jingjing Ma, Chen Chen, Nian Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3431-3447
Open Access
Biochanin A Mitigates Colitis by Inhibiting Ferroptosis-Mediated Intestinal Barrier Dysfunction, Oxidative Stress, and Inflammation via the JAK2/STAT3 Signaling Pathway
Beiying Deng, Kunpeng Wang, Haodong He, et al.
Phytomedicine (2025), pp. 156699-156699
Closed Access
Beiying Deng, Kunpeng Wang, Haodong He, et al.
Phytomedicine (2025), pp. 156699-156699
Closed Access
Acute Severe Ulcerative Colitis in the Modern Era Spotlight on Opioids, Small Molecule Therapy, and Interdisciplinary Communication
Catalina Mulanax, Fernando Velayos
Digestive Diseases and Sciences (2025)
Closed Access
Catalina Mulanax, Fernando Velayos
Digestive Diseases and Sciences (2025)
Closed Access
Epstein-Barr virus infection is an independent risk factor for surgery in patients with moderate-to-severe ulcerative colitis
Hui Zhang, Xi Gu, Wei He, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 16
Closed Access
Hui Zhang, Xi Gu, Wei He, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 16
Closed Access
Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled Study
Hayam A Alrasheed, Sahar M. El-Haggar, Sahar K. Hegazy, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3077-3077
Open Access
Hayam A Alrasheed, Sahar M. El-Haggar, Sahar K. Hegazy, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3077-3077
Open Access
Myeloid Cell-Derived IL-1 Signaling Damps Neuregulin-1 from Fibroblasts to Suppress Colitis-Induced Early Repair of the Intestinal Epithelium
Ding Qiu, Shaoting Xu, Kaile Ji, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4469-4469
Open Access | Times Cited: 2
Ding Qiu, Shaoting Xu, Kaile Ji, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4469-4469
Open Access | Times Cited: 2
Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches
Sara Lauricella, Francesco Brucchi, Federica Cavalcoli, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 580-580
Open Access | Times Cited: 2
Sara Lauricella, Francesco Brucchi, Federica Cavalcoli, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 580-580
Open Access | Times Cited: 2
Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3942-3953
Closed Access | Times Cited: 1
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3942-3953
Closed Access | Times Cited: 1
Future of Acute Severe Ulcerative Colitis—A Narrative Review
Leshni Pillay, Janakan Selvarajah, B. L. Andrew, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7723-7723
Open Access | Times Cited: 1
Leshni Pillay, Janakan Selvarajah, B. L. Andrew, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7723-7723
Open Access | Times Cited: 1
Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions—Authors' reply
María José García, Javier P. Gisbert, María Chaparro
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 2, pp. 300-301
Closed Access
María José García, Javier P. Gisbert, María Chaparro
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 2, pp. 300-301
Closed Access
Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway
Xueni Ma, Muyang Li, Xiaochun Wang, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112572-112572
Closed Access
Xueni Ma, Muyang Li, Xiaochun Wang, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112572-112572
Closed Access
Response to Pinnuck and Lynch
Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 11, pp. 2346-2347
Closed Access
Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 11, pp. 2346-2347
Closed Access
Histological scores are poor predictors of short term outcomes in acute severe ulcerative colitis: An observational study
Shubhra Mishra, Aravind Sekar, Anuraag Jena, et al.
Digestive and Liver Disease (2024)
Closed Access
Shubhra Mishra, Aravind Sekar, Anuraag Jena, et al.
Digestive and Liver Disease (2024)
Closed Access
Recent Advances in the Management of Acute Severe Ulcerative Colitis
Elaine Ong Ming San, Κassem Sharif, Konstantina Rosiou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7446-7446
Open Access
Elaine Ong Ming San, Κassem Sharif, Konstantina Rosiou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7446-7446
Open Access
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis – Authors’ reply
C Li Wai Suen, Matthew C. Choy, Danny Con, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 10, Iss. 1, pp. 19-19
Closed Access
C Li Wai Suen, Matthew C. Choy, Danny Con, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 10, Iss. 1, pp. 19-19
Closed Access
Acute severe ulcerative colitis: defining the precise moment for colectomy
Paulo Gustavo Kotze, Sailish Honap, Mariane Christina Savio, et al.
Expert Review of Gastroenterology & Hepatology (2024), pp. 1-10
Closed Access
Paulo Gustavo Kotze, Sailish Honap, Mariane Christina Savio, et al.
Expert Review of Gastroenterology & Hepatology (2024), pp. 1-10
Closed Access
